CompletedPhase 1NCT00243893

Tetracycline-Derivatives for Treatment of Cerebral Arteriovenous Malformations and Aneurysms

Studying Brain arteriovenous malformation

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of California, San Francisco
Principal Investigator
William L. Young, MD
University of California, San Francisco
Intervention
minocycline(drug)
Enrollment
26 enrolled
Eligibility
13-80 years · All sexes
Timeline
20042008

Study locations (1)

Collaborators

National Institute of Neurological Disorders and Stroke (NINDS)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00243893 on ClinicalTrials.gov

Other trials for Brain arteriovenous malformation

Additional recruiting or active studies for the same condition.

See all trials for Brain arteriovenous malformation

← Back to all trials